About this trial
Emergence from general anesthesia with a laryngeal mask airway compared with an endotracheal tube has been shown to favorable with respect to limiting emergence phenomena such as coughing, straining, restlessness, and sympathetic stimulation leading to hypertension and tachycardia.
Many anesthesiologists would prefer the use of an ETT to an LMA in cases in which higher ventilation pressures may be required, in those patients who are perceived to be high risk for reflux and pulmonary aspiration of gastric contents, as well as during cases that allow the anesthesiologist to have little accessibility the airway.
The aim of this study is to investigate an airway management technique that would allow for the benefits of the ETT in terms of a secure airway for the duration of the surgical procedure as well the potential for less emergence phenomena seen when emerging with an LMA.
Eligibility criteria
Qualifiers
ASA 1-3
Patients undergoing elective laparoscopic surgery
Disqualifiers
Individuals who cannot provide consent
Individuals who would require translation services to provide consent
Prisoners
Parturients
Trial design
Treatments tested in this trial
- Induction of anesthesia
- Placement of LMA [Ambu (R) AuraGain (TM) disposable laryngeal mask]
- Laryngoscopy and placement of ETT
- Ventilation via the ETT
- Removal of the ETT
- Intubation of the trachea through the LMA
- Ventilation via the LMA
- Emergence from anesthesia
Treatment groups
Sponsors and collaborators
Milton S. Hershey Medical Center
Lead sponsor
Ambu A/S
Collaborator